Foghorn Therapeutics (FHTX) Earnings Date & Reports
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FHTX is expected to report earnings to rise 2.84% to -25 cents per share on March 05
Q4'25
Est.
$-0.26
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.12
The last earnings report on November 05 showed earnings per share of -25 cents, beating the estimate of -33 cents. With 127.01K shares outstanding, the current market capitalization sits at 274.84M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FHTX showed earnings on November 05, 2025. You can read more about the earnings report here.